Associate Director, Federal Government Affairs at Bristol-Myers Squibb

Washington, District of Columbia, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Minimum 5-7 years of professional experience working in Congress or other organizations with Congressional focus
Proven ability to translate complex scientific and policy issues into clear, compelling, and politically relevant messages for Congressional audiences
Demonstrated success in building and maintaining strong, non-partisan working relationships with Congressional staff and key D.C. political and policy stakeholders
Exceptional organizational skills and a demonstrated ability to independently manage and execute multiple complex, high-visibility projects and events under tight deadlines
Strategic, creative, and proactive approach to engagement, focused on education and solutions rather than traditional, direct lobbying

Responsibilities

Proactively identify and assess Congressional and external forums (e.g., hearings, caucuses, think tank events) to position BMS messaging
Lead the design and execution of high-impact educational events on Capitol Hill, including briefings, panels, and policy roundtables
Secure and staff opportunities for BMS experts and executives to speak at external forums, positioning BMS as the authoritative policy voice
Serve as the central hub for policy materials and intelligence to directly support and enable the Federal Affairs lobbying team
Act as the internal point of contact to gather, synthesize, and disseminate current data and messaging from internal teams and external trade groups
Quickly mobilize resources to capitalize on opportunities flagged by lobbyists, such as securing witness seats for key hearings or panels
Ensure timely, compelling information is consistently available to the entire team to support direct lobbying efforts and external engagement
Collaborate closely with Federal Government Affairs, Policy, and Alliance Development teams to ensure unified approach to any Congressional engagements

Skills

Government Affairs

Federal Policy

Stakeholder Engagement

Congressional Outreach

Policy Communication

Strategic Planning

Event Management

Healthcare Policy

Public Affairs

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free